Synthesis and anticonvulsant activity of new 2,3-benzodiazepines as AMPA receptor antagonists

Hicks, 1995, The role of glutamate and its receptors in synaptic transmission, 201 Conn, 1997, Pharmacology and functions of metabotropic glutamate receptors, Annu. Rev. Pharmacol. Toxicol., 37, 205, 10.1146/annurev.pharmtox.37.1.205 P. Krogsgaard-Larsen, J.J. Hansen (Eds.), Excitatory Amino Acid Receptors: Design of Agonists and Antagonists, Ellis Horwood, Chichester, UK, 1992. D.T. Monaghan, R.J. Wenthold (Eds.), The Ionotropic Glutamate Receptors, Humana Press, New Jersey, 1997. Ikonomidou, 1995, Glutamate in neurodegenerative disorders, 253 Danysz, 1995, Glutamate in CNS disorders, Drug News Perspect., 8, 261 Krogsgaard-Larsen, 1996, Design of excitatory amino acid receptor agonists, partial agonists and antagonists: ibotenic acid as a key lead structure, Eur. J. Med. Chem., 31, 515, 10.1016/0223-5234(96)89549-3 B.S. Meldrum (Ed.), Excitatory Amino Acid Antagonists, Blackwell, London, 1991. Rogawski, 1992, The NMDA receptor, NMDA antagonists and epilepsy therapy, Drugs, 44, 279, 10.2165/00003495-199244030-00001 Koek, 1988, MK-801, a proposed non-competitive antagonist of excitatory amino acid neurotransmission, produces phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys, J. Pharmacol. Exp. Ther., 245, 969 Herting, 1993, Competitive NMDA antagonists: results from animal models and first results in human, J. Neurochem. (Suppl.), 61, S283C Morris, 1986, Selective impairment of learning and blockade of long-term potentiation by an N-methyl-d-aspartate receptor antagonist, AP5, Nature, 319, 774, 10.1038/319774a0 Desos, 1996, Structure–activity relationships in a series of 2(1H)-quinolones bearing different function in the 3-position: 6,7-dichloro-2(1H)-oxoquinoline-3-phosphonic acid, a new potent and selective AMPA/kainate antagonist with neuroprotective properties, J. Med. Chem., 39, 197, 10.1021/jm950323j Lin, 1997, Molecular targets for the rational design of antiepileptic drugs and related neuroprotective agents, Med. Res. Rev., 17, 537, 10.1002/(SICI)1098-1128(199711)17:6<537::AID-MED3>3.0.CO;2-2 Sheardown, 1990, 2,3-Dihydroxy-6-nitro-7-sulfamoylbenzo[f]quinoxaline: a neuroprotectant for cerebral ischemia, Science, 247, 571, 10.1126/science.2154034 Buchan, 1993, AMPA antagonists: do they hold more promise for clinical stroke trials than NMDA antagonists?, Stroke (Suppl. I), 24, 148 Ohmori, 1994, 6-(1H-Imidazol-1-yl)-7-nitro-2,3(1H,4H)-quinoxalinedione hydrochloride (YM90K) and related compounds: structure–activity relationships for the AMPA-type non-NMDA receptor, J. Med. Chem., 37, 467, 10.1021/jm00030a006 Donevan, 1993, GYKI 52466, a 2,3-benzodiazepine, is a highly selective, non-competitive antagonist of AMPA/kainate receptor responses, Neuron, 10, 51, 10.1016/0896-6273(93)90241-I Rogawski, 1993, Therapeutic potential of excitatory amino acid antagonists: channel blockers and 2,3-benzodiazepines, Trends Pharmacol. Sci., 14, 325, 10.1016/0165-6147(93)90005-5 Chapman, 1991, The anticonvulsant effect of the non-NMDA antagonists, NBQX and GYKI 52466 in mice, Epilepsy Res., 9, 92, 10.1016/0920-1211(91)90018-B Smith, 1991, The non-N-methyl-d-aspartate receptor antagonists, GYKI 52466 and NBQX are anticonvulsant in two animal models of reflex epilepsy, Eur. J. Pharmacol., 201, 179, 10.1016/0014-2999(91)90342-N Chapman, 1993, Aniracetam reverses the anticonvulsant action of NBQX and GYKI 52466 in DBA/ 2 mice, Eur. J. Pharmacol., 231, 301, 10.1016/0014-2999(93)90465-T Donevan, 1994, Non-N-methyl-d-aspartate receptor antagonism by 3-N-substituted 2,3-benzodiazepines: relationship to anticonvulsant activity, J. Pharmac. Exp. Ther., 271, 25 Smith, 1992, Cerebroprotective effect of a non-N-methyl-d-aspartate antagonist, GYKI 52466, after focal ischemia in the rat, Stroke, 23, 861, 10.1161/01.STR.23.6.861 Arvin, 1994, Effect of the non-NMDA receptor antagonist GYKI 52466 on the microdialyzate and tissue concentrations of amino acids following transient forebrain ischemia, J. Neurochem., 62, 1458, 10.1046/j.1471-4159.1994.62041458.x Tarnawa, 1989, Electrophysiological studies with a 2,3-benzodiazepine muscle relaxant: GYKI 52466, Eur. J. Pharmacol., 67, 193, 10.1016/0014-2999(89)90579-7 De Sarro, 1995, GYKI 52466 and related 2,3-benzodiazepines as anticonvulsant agents in DBA/2 mice, Eur. J. Pharmacol., 294, 411, 10.1016/0014-2999(95)00561-7 Chimirri, 1997, 1-Aryl-3,5-dihydro-4H-2,3-benzodiazepin-4-ones: novel AMPA receptor antagonists, J. Med. Chem., 40, 1258, 10.1021/jm960506l Chapman, 1984, Evaluation of anticonvulsant drugs in DBA/2 mice with sound-induced seizures, Arzneim. Forsch., 34, 1261 Engstrom, 1988, Seizure susceptibility in DBA/2 and C57 mice: the effects of various convulsants, Epilepsia, 29, 389, 10.1111/j.1528-1157.1988.tb03736.x Ito, 1990, Allosteric potentiation of quisqualate receptors by nootropic drug aniracetam, J. Physiol. (London), 424, 533, 10.1113/jphysiol.1990.sp018081 De Sarro, 1998, 7,8-Methylenedioxy-4H-2,3-benzodiazepin-4-ones as novel AMPA receptor antagonists, Bioorg. Med. Chem. Lett., 8, 971, 10.1016/S0960-894X(98)00148-6 Schuda, 1983, A facile method for the oxidative removal of benzyl ethers: the oxidation of benzyl ethers to benzoate by ruthenium tetraoxide, Tetrahedron Lett., 24, 3829, 10.1016/S0040-4039(00)94286-2 Chapman, 1989, Non-competitive N-methyl-d-aspartate antagonists protect against sound-induced seizures in DBA/2 mice, Eur. J. Pharmacol., 166, 201, 10.1016/0014-2999(89)90060-5 De Sarro, 1993, Anticonvulsant properties of non-competitive antagonists of NMDA receptor in genetically epilepsy prone rats. Comparison with CPPene, Neuropharmacology, 32, 51, 10.1016/0028-3908(93)90129-Q McEntee, 1993, Glutamate, its role in learning, memory, and the aging brain, Psychopharmacology, 111, 391, 10.1007/BF02253527 Chiamulera, 1990, Effect of NMDA- and strychnine-insensitive glycine site antagonists on NMDA-mediated convulsions and learning, Psychopharmacology, 102, 551, 10.1007/BF02247140 Bliss, 1993, A synaptic model of memory: long-term potentiation in the hippocampus, Nature, 361, 31, 10.1038/361031a0 Paternain, 1995, Selective antagonism of AMPA receptors unmasks kainate receptor–mediate responses in hippocampal neurones, Neuron, 14, 185, 10.1016/0896-6273(95)90253-8 Daly, 1986, Analogues of 1,3-dipropyl-8-phenylxanthines: enhancement of selectivity at A1-adenosine receptors by aryl substituents, J. Med. Chem., 29, 1520, 10.1021/jm00158a034 Collins, 1972, Audiogenic seizures, 347 Swinyard, 1952, Comparative assays of antiepileptic in mice and rats, J. Pharmacol. Exp. Ther., 106, 319 Swinyard, 1982, Experimental detection, quantification and evaluation of anticonvulsants, 111 De Sarro, 1994, Excitatory amino acid neurotransmission through both NMDA and non-NMDA receptors is involved in the anticonvulsant activity of felbamate in DBA/2 mice, Eur. J. Pharmacol., 262, 11, 10.1016/0014-2999(94)90022-1 Dunham, 1957, A note on a simple apparatus for detecting neurological deficit in rats and mice, J. Am. Pharm. Ass., 46, 208, 10.1002/jps.3030460322 Litchfield, 1949, A simplified method of evaluating dose–effects experiments, J. Pharmac. Exp. Ther., 96, 99 G.I. McPherson, ligand (release 2.0), Elsevier Biosoft, Cambridge, 1987.